Brinton Pharma Gets DCGI Mod to Market Favipiravir for Covid-19 Treatment, to be Sold at Rs 59 Per Tablet - Newshunt | Latest and Breaking News, India News & World News

Home india Brinton Pharma Gets DCGI Mod to Market Favipiravir for Covid-19 Treatment, to be Sold at Rs 59 Per Tablet

Brinton Pharma Gets DCGI Mod to Market Favipiravir for Covid-19 Treatment, to be Sold at Rs 59 Per Tablet

July 23, 2020

In India, Favipiravir was first approved by the regulatory authorities in June 2020 under emergency use authorisation to treat COVID-19 patients, Brinton Phar.

from India News: Latest India News | India Live News Online | Current News - News18 - News18
Read The Rest:indianexpress...